Boston Scientific
BSX
BSX
859 hedge funds and large institutions have $51.4B invested in Boston Scientific in 2022 Q3 according to their latest regulatory filings, with 82 funds opening new positions, 331 increasing their positions, 291 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
859
Holders Change
-14
Holders Change %
-1.6%
% of All Funds
14.85%
Holding in Top 10
22
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+4.76%
% of All Funds
0.38%
New
82
Increased
331
Reduced
291
Closed
85
Calls
$232M
Puts
$252M
Net Calls
-$19.8M
Net Calls Change
-$19.2M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$878M |
| 2 |
Amundi
Paris,
France
|
+$213M |
| 3 |
Goldman Sachs
New York
|
+$196M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$161M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
+$82.4M |
Top Sellers
| 1 |
Parnassus Investments
San Francisco,
California
|
-$585M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$112M |
| 3 |
Neuberger Berman Group
New York
|
-$76.7M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$67.6M |
| 5 |
Two Sigma Advisers
New York
|
-$56.9M |
